Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IBI3003 |
Synonyms | |
Therapy Description |
IBI3003 is a T-cell engager targeting GPRC5D and TNFRSF17 (BCMA) on tumor cells and CD3 on T-cells, which potentially induces a cytotoxic T-cell response against tumor cells expressing GPRC5D and TNFRSF17 (BCMA) (NCI Drug Dictionary). |